This book describes the potential therapeutic benefits of algae in the management of diabetes. The work mainly focuses on the anti-diabetic properties of different types of algae, both marine and freshwater. The chapters present various bioactive compounds that exhibit anti-diabetic effects, finding their mechanisms of action and potential applications in diabetes management. These compounds may include polysaccharides, polyphenols, pigments etc. which have been identified for their ability to regulate glucose metabolism, improve the level of insulin sensitivity, and mitigate complications…mehr
This book describes the potential therapeutic benefits of algae in the management of diabetes. The work mainly focuses on the anti-diabetic properties of different types of algae, both marine and freshwater. The chapters present various bioactive compounds that exhibit anti-diabetic effects, finding their mechanisms of action and potential applications in diabetes management. These compounds may include polysaccharides, polyphenols, pigments etc. which have been identified for their ability to regulate glucose metabolism, improve the level of insulin sensitivity, and mitigate complications associated with the diabetes. The book aims to provide a foundation in the field of algae for diabetes. By consolidating the latest knowledge and highlighting the gaps in current understanding, it helps the fractionation of particular compounds, characterization, and clinical applications. Algae, with their rich biochemical resources and potential health benefits, represent an exciting avenue for exploration in the quest for novel anti-diabetic agents. The work contributes to the scientific analysis to explore the unexploited potential of algae in the area of diabetes management.
Rathinam Raja is a Professor and Director of the Centre for Integrative Medical Research at Sree Balaji Medical College and Hospital, Chennai. He did his Post-Doctoral Fellowships in Taiwan, South Korea, and IIT Madras and worked as a Lead Scientist at Louisiana. He was also an Auxiliary Investigator at the University of the Algarve. He has published fifty articles, fourteen chapters, six books and five patents. He has visited more than twenty countries to present his research findings. Dr. S. Hemaiswarya is a Senior Scientist at Fib-Sol Life Technologies, Chennai. She received her Ph.D. from IIT Madras followed by research experience at the University of Algarve for couple of years. She received a three-year Women Scientist (WOS-A) fellowship from the Department of Science and Technology, India and completed the project at Anna University. She also worked as a Project Officer at the Department of Biotechnology, IIT Madras and as a Scientist at IIT M Research Park, Chennai. As an outset, she has published thirty five articles, twelve chapters, seven books and three patents. Dr. Muthusamy Sanjivkumar is an Assistant Professor of Microbiology at K.R. College of Arts and Science, Kovilpatti, Tamil Nadu, India. He received his Ph.D. in Microbiology-Marine Biotechnology from the Centre for Marine Science and Technology, Manonmaniam Sundaranar University. He has expertise in microbio-active compounds, mangrove microbiome, and actinobacterial research fields. Dr. Tamilselvan Silambarasan is an Assistant Professor at the Helix Research Center, Department of General Medicine, Saveetha Medical College and Hospital, SIMATS, Saveetha University, Chennai, India. He received his Ph.D. in Microbiology-Biotechnology in 2017. Dr. Silambarasan’s research interests in Algal Biotechnology, Enzyme Technology, and Drug Discovery. Dr. Grasian Immanuel is an Associate Professor and Director of the Centre for Marine Science & Technology (CMST) and Post Graduate Extension Centre, Manonmaniam Sundaranar University, Kanyakumari District, Tamil Nadu, India. He pursued his Ph.D. (Marine Biotechnology) at M.S. University and Post-Doctoral Research at the Department of Biology, University of South Pacific, Suva, Republic of Fiji in 2002. He has sound expertise in Marine Food Processing and Marine Natural Products Production & Applications.
Inhaltsangabe
Chapter 1. Mechanism of action and signalling pathways of Diabetes. Chapter 2. Diabetes: Current treatment and its management. Chapter 3. Diabetes: Secondary metabolites/active molecules from algae. Chapter 4. Antidiabetic properties of microalgae compounds. Chapter 5. Macroalgae with antidiabetic properties. Chapter 6. Antidiabetic Secondary Metabolites and Active Molecules from Algae. Chapter 7. Algae to the Rescue: Unveiling the Potential Role of Neuroprotection in Diabetic Neuropathy. Chapter 8. Diabetic induced nephropathy and its mitigation by algae. Chapter 9. Nutraceutical Potential of Algae in Reducing Obesity Related to Diabetes. Chapter 10. Mitigation of Diabetes and Cardiovascular Complications by Algae. Chapter 11. Cardio protective and Anti obesity Properties of Polyunsaturated Fatty Acids from Algae. Chapter 12. Algal Pigments and Diabetes. Chapter 13. Clinical trials and patents Related to anti diabetic properties of algae. Chapter 14. Biomaterial Composites with Algal Polysaccharides for the Treatment of Diabetes Foot Ulcers. Chapter 15. Preclinical Animal Studies on the Antidiabetic Potential of Algae. Chapter 16. Drug delivery and Nanotechnology to enhance anti diabetic properties of algae. Chapter 17. Computational Insights into Algal Compounds for Diabetes Mellitus Management. Chapter 18. Economic and Environmental Impact of Algae in Diabetic Management. Chapter 19. Reactive Oxygen Species in Algae: Antidiabetic benefits. Chapter 20. Future prospects and potential challenges of understanding antidiabetic potential of algae.
Chapter 1. Mechanism of action and signalling pathways of Diabetes. Chapter 2. Diabetes: Current treatment and its management. Chapter 3. Diabetes: Secondary metabolites/active molecules from algae. Chapter 4. Antidiabetic properties of microalgae compounds. Chapter 5. Macroalgae with antidiabetic properties. Chapter 6. Antidiabetic Secondary Metabolites and Active Molecules from Algae. Chapter 7. Algae to the Rescue: Unveiling the Potential Role of Neuroprotection in Diabetic Neuropathy. Chapter 8. Diabetic induced nephropathy and its mitigation by algae. Chapter 9. Nutraceutical Potential of Algae in Reducing Obesity Related to Diabetes. Chapter 10. Mitigation of Diabetes and Cardiovascular Complications by Algae. Chapter 11. Cardio protective and Anti obesity Properties of Polyunsaturated Fatty Acids from Algae. Chapter 12. Algal Pigments and Diabetes. Chapter 13. Clinical trials and patents Related to anti diabetic properties of algae. Chapter 14. Biomaterial Composites with Algal Polysaccharides for the Treatment of Diabetes Foot Ulcers. Chapter 15. Preclinical Animal Studies on the Antidiabetic Potential of Algae. Chapter 16. Drug delivery and Nanotechnology to enhance anti diabetic properties of algae. Chapter 17. Computational Insights into Algal Compounds for Diabetes Mellitus Management. Chapter 18. Economic and Environmental Impact of Algae in Diabetic Management. Chapter 19. Reactive Oxygen Species in Algae: Antidiabetic benefits. Chapter 20. Future prospects and potential challenges of understanding antidiabetic potential of algae.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826